Evidence map›Paper›PMID 33202111›Full record

ArticleArthritis care & research2022

Novel Framework for Measuring Whole Knee Osteoarthritis Progression Using Magnetic Resonance Imaging.

Jeffrey B Driban, Lori Lyn Price, Michael P LaValley, Grace H Lo, Ming Zhang, Matthew S Harkey, Amanda Canavatchel, Timothy E McAlindon

Abstract read
In one paragraph

Article in Arthritis care & research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jeffrey B DribanTufts Medical Center, Boston, Massachusetts.ORCID 0000-0001-6098-4273
Lori Lyn PriceTufts University and Tufts Medical Center, Boston, Massachusetts.ORCID 0000-0003-0664-8978
Michael P LaValleyBoston University School of Public Health, Boston, Massachusetts.
Grace H LoBaylor College of Medicine, Houston, Texas.ORCID 0000-0003-3142-1839
Ming ZhangTufts Medical Center, Boston, Massachusetts.
Matthew S HarkeyTufts Medical Center, Boston, Massachusetts.ORCID 0000-0002-3480-3173
Amanda CanavatchelTufts Medical Center, Boston, Massachusetts.
Timothy E McAlindonTufts Medical Center, Boston, Massachusetts.

Funding

Tufts Clinical and Translational Science Institute (Pilot Supplement)UL1TR002544 · NCATS · TUFTS UNIVERSITY BOSTON · PI SELKER, HARRY P. · 2018 to 2022
$50.2M
University of Massachusetts Center for Clinical and Translational ScienceTL1TR001454 · NCATS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI LEWIS, BRIAN C · 2015 to 2024
$3.6M
Modifiable Risk Factors for Incident and Progressive Early Knee OsteoarthritisK23AR062127 · NIAMS · BAYLOR COLLEGE OF MEDICINE · PI LO, GRACE · 2012 to 2016
$676k
Rapid Quantitative Composite MRI Measurement of Knee OA Structural ProgressionU01AR067168 · NIAMS · TUFTS MEDICAL CENTER · PI MCALINDON, TIMOTHY E · 2014 to 2016
$660k
NCATS NIH HHS TL1 TR001454NCATS NIH HHS UL1 TR002544NIAMS NIH HHS K23 AR062127NIAMS NIH HHS U01 AR067168
6 · The paper itself

Abstract

objectiveWe developed and validated a set of composite scores that combine quantitative magnetic resonance imaging (MRI)-based measurements of hyaline cartilage damage, bone marrow lesions (BMLs), and effusion-synovitis into composite scores.

methodsWe selected 300 participants (n = 100 for development cohort; n = 200 for validation cohort) from the Osteoarthritis Initiative with complete clinical, radiographic, and MRI data at baseline and 24 months. We used semiautomated programs to quantify tibiofemoral and patellar cartilage damage, BML volume, and whole-knee effusion-synovitis volume. The candidate composite scores were formed by summing changes from baseline to 24 months based on prespecified methods. We evaluated the candidate composite scores for 1) the ability to differentiate groups with and without knee osteoarthritis progression (17 radiographic and patient-reported definitions), 2) sensitivity to change (standardized response means), and 3) relative performance relating to legacy outcome measures of knee osteoarthritis progression.

resultsThree of 13 developed composite scores qualified for testing in the validation cohort (ranked by sensitivity to change): whole-knee cumulative cartilage damage, unweighted total knee score, and BML plus effusion-synovitis volume. Change in cumulative cartilage damage associated with radiographic progression (Kellgren/Lawrence grade: odds ratio [OR] 1.84; joint space width progression: OR 2.11). Changes in the unweighted total knee score (OR 1.97) and BML plus effusion-synovitis score (OR 1.92) associated with Western Ontario and McMaster Universities Osteoarthritis Index knee pain progression.

conclusionTwo composite scores emerged, reflecting discrete domains of knee osteoarthritis progression. First, cumulative damage, which is measured by a whole-knee cartilage damage score, reflects the damage accrued over time. Second, dynamic disease activity, which is measured by a BML plus effusion-synovitis score, relates to changes in a patient's state of disease and symptoms.

Indexed as

Cartilage DiseasesOsteoarthritis, KneeSynovitisHumansKnee JointMagnetic Resonance Imaging

Identifiers

PMID33202111
PMCPMC8631200

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.